Cargando…
Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy
BACKGROUND: To investigate differences in the performance of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for glucose abnormalities after shifting from glucose-based diagnostic criteria to the proposed new hemoglobin (Hb)A1c-based criteria. METHODS: A cross-sectional primary-care s...
Autores principales: | Costa, Bernardo, Barrio, Francisco, Piñol, Josep L, Cabré, Joan J, Mundet, Xavier, Sagarra, Ramon, Salas-Salvadó, Jordi, Solà-Morales, Oriol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621796/ https://www.ncbi.nlm.nih.gov/pubmed/23438147 http://dx.doi.org/10.1186/1741-7015-11-45 |
Ejemplares similares
-
Effect of biological variation in HbA1c and blood glucose on the diagnosis of prediabetes
por: Hempe, James M., et al.
Publicado: (2023) -
Discordance in the diagnosis of diabetes: Comparison between HbA1c and fasting plasma glucose
por: Ho-Pham, Lan T., et al.
Publicado: (2017) -
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance
por: Bianchi, Cristina, et al.
Publicado: (2012) -
FINDRISC in Latin America: a systematic review of diagnosis and prognosis models
por: Carrillo-Larco, Rodrigo M, et al.
Publicado: (2020) -
Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population
por: Bernabe-Ortiz, Antonio, et al.
Publicado: (2018)